Our high-throughput analyses at the RNA and protein levels showed consistent alterations in histone modification pathways in LDE225-resistant SI-CSC medulloblastomas in both the FSmoM2;hGFAP-cre and Ptch;p53 models. The gene discussed is TP53; the disease is medulloblastoma.